[go: up one dir, main page]

EP1859063A4 - Replikin-peptide und anwendungen - Google Patents

Replikin-peptide und anwendungen

Info

Publication number
EP1859063A4
EP1859063A4 EP06735145A EP06735145A EP1859063A4 EP 1859063 A4 EP1859063 A4 EP 1859063A4 EP 06735145 A EP06735145 A EP 06735145A EP 06735145 A EP06735145 A EP 06735145A EP 1859063 A4 EP1859063 A4 EP 1859063A4
Authority
EP
European Patent Office
Prior art keywords
replikin peptides
replikin
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06735145A
Other languages
English (en)
French (fr)
Other versions
EP1859063A2 (de
Inventor
Samuel Dr Bogoch
Elenore S Bogoch
Samuel Winston Bogoch
Anne-Elenore Bogoch Borsanyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/014443 external-priority patent/WO2005104754A2/en
Application filed by Individual filed Critical Individual
Publication of EP1859063A2 publication Critical patent/EP1859063A2/de
Publication of EP1859063A4 publication Critical patent/EP1859063A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Pulmonology (AREA)
  • Pathology (AREA)
EP06735145A 2005-02-16 2006-02-16 Replikin-peptide und anwendungen Withdrawn EP1859063A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65308305P 2005-02-16 2005-02-16
PCT/US2005/014443 WO2005104754A2 (en) 2004-04-28 2005-04-28 System and method for identifying complex patterns of amino acids
PCT/US2006/005343 WO2006088962A2 (en) 2005-02-16 2006-02-16 Replikin peptides and uses thereof

Publications (2)

Publication Number Publication Date
EP1859063A2 EP1859063A2 (de) 2007-11-28
EP1859063A4 true EP1859063A4 (de) 2012-02-01

Family

ID=36917023

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06735145A Withdrawn EP1859063A4 (de) 2005-02-16 2006-02-16 Replikin-peptide und anwendungen

Country Status (8)

Country Link
EP (1) EP1859063A4 (de)
JP (1) JP2008539164A (de)
AU (1) AU2006214332B2 (de)
CA (1) CA2598381A1 (de)
IL (1) IL185308A0 (de)
NZ (1) NZ560415A (de)
SG (1) SG160327A1 (de)
WO (1) WO2006088962A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7420028B2 (en) 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US20080260764A1 (en) * 2006-05-30 2008-10-23 Samuel Bogoch Replikin peptides and uses thereof
EP2092059A4 (de) 2006-10-24 2012-03-28 Bogoch Samuel Verfahren zur vorhersage von influenza-ausbrüchen durch korrelation eines erhöhten replikin-spiegels in white-spot- und/oder taura-viren bei krabben
JP2011516027A (ja) * 2007-01-18 2011-05-26 ボゴーク，サミュエル レプリキンピーク遺伝子が関与する病原体および悪性腫瘍の致死性を判定する方法
WO2008156914A2 (en) * 2007-05-30 2008-12-24 Samuel Bogoch Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
WO2009132209A2 (en) * 2008-04-23 2009-10-29 Samuel Bogoch Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
AU2009279428A1 (en) * 2008-08-08 2010-02-11 Elenore S. Bogoch Methods of predicting cancer lethality using Replikin counts
US9233148B2 (en) * 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
EP2421546A1 (de) * 2009-04-23 2012-02-29 Samuel Bogoch Replikin-sequenzen zur prävention/behandlung von grippe und bestimmung von infektiosität/letalität
AU2012283914A1 (en) 2011-07-20 2014-01-30 Bogoch, Elanore S. Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
SG11201405447QA (en) 2012-03-09 2014-10-30 Samuel Bogoch Therapies, vaccines, and predictive methods for infectious salmon anemia virus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020151677A1 (en) * 2001-03-27 2002-10-17 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0221748A3 (de) 1985-11-01 1988-10-12 Samuel Dr. Bogoch Verfahren zur Herstellung von menschlichen Antikörpern
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US6242578B1 (en) 1994-02-17 2001-06-05 Samuel Bogoch Aglyco products and methods of use
US7442761B2 (en) * 2003-06-06 2008-10-28 Samuel Bogoch Replikin peptides and uses thereof
US11620305B2 (en) 2021-03-25 2023-04-04 Salesforce.Com, Inc Ruleset engine for generating homogeneous data sets

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020151677A1 (en) * 2001-03-27 2002-10-17 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BOGOCH S, BOGOCH ES: "Rapid replication and Replikintm structures: basis of the AMASRTest and CAVAXR.", CANCER DETECTION AND PREVENTION ONLINE, 9 February 2002 (2002-02-09), XP002350483 *
See also references of WO2006088962A2 *

Also Published As

Publication number Publication date
WO2006088962A2 (en) 2006-08-24
WO2006088962A3 (en) 2008-01-24
CA2598381A1 (en) 2006-08-24
NZ560415A (en) 2010-05-28
IL185308A0 (en) 2008-02-09
AU2006214332A1 (en) 2006-08-24
JP2008539164A (ja) 2008-11-13
AU2006214332B2 (en) 2012-03-22
EP1859063A2 (de) 2007-11-28
WO2006088962A9 (en) 2006-11-16
SG160327A1 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
IL228770A0 (en) processes and intermediates
IL184428A0 (en) Peptides with neuropeptide-2-receptor
IL222922A (en) Antibodies against neurophilin-1 and their use
EP1976864A4 (de) Neues peptid und seine verwendung
IL185308A0 (en) Replikin peptides and uses thereof
IL187617A0 (en) Lkktet and/or lkktnt peptide compositions and methods
IL179497A0 (en) Carboranylporphyrins and uses thereof
GB0508863D0 (en) Peptide
GB0621513D0 (en) Novel polypeptides and uses thereof
IL195525A0 (en) Replikin peptides and uses thereof
GB0604187D0 (en) Peptide and uses thereof
IL180365A0 (en) Carboranylporphyrins and uses thereof
ZA200801874B (en) Antigenic peptides and their use
EP1953227A4 (de) Lipopolysaccharid- oder lipid-a-bindemittel und neues peptid
GB0517293D0 (en) Vectors and uses thereof
GB0526019D0 (en) Peptides
GB0516527D0 (en) Peptides
GB0617564D0 (en) Peptides and methods
IL192800A0 (en) Fgf2-binding peptides and uses thereof
GB0516571D0 (en) Novel polypeptides and uses thereof
GB0517813D0 (en) Peptides and uses thereof
EP1910405A4 (de) Von komplement c3a abgeleitete peptide und anwendungen davon
GB0612873D0 (en) Isolated peptides and uses thereof
GB0425731D0 (en) Isolated peptides and uses thereof
GB0503093D0 (en) Ricin-binding peptide and methods for use thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070912

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

R17D Deferred search report published (corrected)

Effective date: 20080124

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1116833

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20111230

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/68 20060101ALN20111223BHEP

Ipc: C07K 14/11 20060101ALN20111223BHEP

Ipc: C07K 16/10 20060101ALI20111223BHEP

Ipc: G01N 33/50 20060101ALI20111223BHEP

Ipc: G06F 17/00 20060101ALI20111223BHEP

Ipc: G06F 19/00 20110101AFI20111223BHEP

17Q First examination report despatched

Effective date: 20120113

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1116833

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150901